By Robb M. Stewart
PLx Pharma Inc.'s shares jumped Tuesday ahead of the launch of its liquid-filled aspirin capsules in Walgreens stores in the U.S. next month.
In morning trading, the shares were 17% higher at $19.95, adding to a strong rally since the end of last year.
PLx late Monday said its U.S. Food and Drug Administration-approved Vazalore will be available in more than 8,000 Walgreens stores nationwide later in August. The retail pharmacy has already inserted placeholders to reserve space on shelves for the three variants of Vazalore, a 81 mg 12 count, 81 mg 30 count and a 325 mg 30 count, it said.
Write to Robb M. Stewart at firstname.lastname@example.org
(END) Dow Jones Newswires